NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Viemed Healthcare, Inc. (VMD) Stock Analysis

Viemed Healthcare, Inc. (VMD) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

VMD

$9.08

+$0.07 (+0.78%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare VMD with… →

VMD Key Statistics

As of Sep 4, 2026
Trading
Open
$9.03
Previous Close
$9.01
Day's Range
8.95–9.13
52-Week Range
6.05–12.61
Volume
185.60K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.09
Valuation
Market Cap
$345.84M
P/E Ratio
25.22
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
22.70
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.86
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.15
EPS (ttm)Profit attributable to each share over the last twelve months.
0.36
Financials (FY)
Revenue (FY)
$270.28M+20.52%
Net Income (FY)
$14.93M+32.57%
Profit marginThe share of revenue left as profit after all costs and taxes.
4.81%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
38.09M
1-Year Return
+33.14%
Dividend and dates
Earnings Date
November 4, 2026estimated
Avg Volume
377.86K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

VMD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+22.21%
2025−7.36%
2024+2.17%
2023+3.84%
2022+44.83%
2021−32.73%
2020+25.16%
2019 (partial year)−11.68%

As of September 4, 2026.

VMD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$270.28M$14.93M5.5%
2024$224.26M$11.27M5.0%
2023$183.01M$10.24M5.6%
2022$138.83M$6.22M4.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$270.28M$155.46M$20.71M$14.93M5.5%
2024$224.26M$133.20M$16.00M$11.27M5.0%
2023$183.01M$112.78M$14.98M$10.24M5.6%
2022$138.83M$84.68M$8.60M$6.22M4.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

VMD Valuation vs Medical Devices Median

Median of 151 stocks
MetricVMDMedical Devices medianvs median
P/E25.2226.806% below
P/S ratio1.152.9861% below
Profit margin4.81%−1.69%6.5 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 8 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Viemed Healthcare, Inc. (VMD) carries a market capitalisation of $345.84M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 1,438 employees.

The 52-week range on file runs from $6.05 to $12.61. The most recent close on file for VMD is $9.08, dated September 4, 2026. That is +$0.07 (+0.78%) against the previous close. The latest close sits 50.08% above that 52-week low.

Financial Health

In fiscal 2025, Viemed Healthcare, Inc. reported revenue of $270.28M. That is +20.52% against the prior fiscal year, when revenue was $224.26M. The same year closed with net income of $14.93M. That is +32.57% against the prior fiscal year. Profit margin runs at 4.81%. That is 6.5 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to 0.36.

Across the 4 fiscal years on file, revenue moves from $138.83M in 2022 to $270.28M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 25.22. That is 5.9% below the Medical Devices median of 26.8. On forward earnings the ratio is 22.7. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.86. The price-to-sales ratio is 1.15. On price-to-sales that is 61.47% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Beta against the wider market is reported at 1.09. Daily returns over the trailing 7 years annualize to a volatility of 48.4%. Over the trailing twelve months the price has returned +33.14%. Across 5 years the annualized return works out at +6.56%.

Growth & Income

The record shows no dividend for VMD.

So far in 2026 the price is +22.21%. The strongest complete calendar year on file is 2022 at +44.83%; the weakest is 2021 at −32.73%. Of the 6 complete calendar years on file, 4 finished higher.

Peer Comparison

Viemed Healthcare, Inc. (VMD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Viemed Healthcare, Inc. VMD $345.84M 25.2
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Viemed Healthcare, Inc. trades at a P/E of 25.2.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Viemed Healthcare, Inc.

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Visit website →